Jun
2026
Shanghai New International Expo Center
Visit us
stand E3B50, Finished Dosage

Visum Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2026
About Us

Visum Pharmaceutical Co., Ltd. located in Haikou High-tech Development Zone, was founded in June 2010 by 3 U.S.-trained Ph.D. scientists. Our facility has been inspected 5 times by U.S. FDA and multiple times by Chinese NMPA in the past several years. Visum has 15 products (inc. CDMO) marketed in China and US with the highest annual export volume of sustained-release formulations exceeding 450 million tablets. Visum are forging an integrated pharmaceutical enterprise focused on the R&D and commercialization of advanced dosage forms, dedicated to advancing global health.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E3B50, Finished Dosage

Products Featured at CPHI & PMEC China 2026

  • Analytical Method Develpment and Validation

    Product Analytical Method Develpment and Validation

    Providing Analytical method development, validation and stability study from Phase I-III to commercial prodcution and registration.
  • CDMO- Generics/OTCs in Tablets, Capsules, Granules...

    Product CDMO- Generics/OTCs in Tablets, Capsules, Granules...

    FDA approved facility in China providing Contract Development and Manufacturing Services in Various Dosage Forms: • Tablets • Capsules • Granules/Powder for OS • Oral Solutions • Drops • Ointment • Cream • Gel

    Applicable for most generics/OTCs and innovative drugs.
  • Clinical Supply Manufacturing

    Product Clinical Supply Manufacturing

    NCEs • Phase I-III formulation process development and clinical supply manufacturing Generic drugs
    • BE sample manufacturing • Process Optimization
  • Commercial Manufacturing (CMO)

    Product Commercial Manufacturing (CMO)

    Standards: • US, EU, China, WHO Commercial Scales
    • Tablets: 3 billion/year • Capsules: 500 million/year • Oral solution: 100 million/year • Ointment: 50 million/year • Granules: 300 million/year
  • Formulation Development

    Product Formulation Development

    NCEs • Phase I-III formulation and development Generic Drugs • Pharmaceutical, analytical method development and process study